These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8971038)
1. The prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus. Jolicoeur P; Massé G; Kay DG J Virol; 1996 Dec; 70(12):9031-4. PubMed ID: 8971038 [TBL] [Abstract][Full Text] [Related]
2. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. Gravel C; Kay DG; Jolicoeur P J Virol; 1993 Nov; 67(11):6648-58. PubMed ID: 8411367 [TBL] [Abstract][Full Text] [Related]
3. Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genes. Jolicoeur P; Hu C; Mak TW; Martinou JC; Kay DG J Virol; 2003 Dec; 77(24):13161-70. PubMed ID: 14645573 [TBL] [Abstract][Full Text] [Related]
4. Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Paquette Y; Hanna Z; Savard P; Brousseau R; Robitaille Y; Jolicoeur P Proc Natl Acad Sci U S A; 1989 May; 86(10):3896-900. PubMed ID: 2542954 [TBL] [Abstract][Full Text] [Related]
5. Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. Paquette Y; Kay DG; Rassart E; Robitaille Y; Jolicoeur P J Virol; 1990 Aug; 64(8):3742-52. PubMed ID: 2164594 [TBL] [Abstract][Full Text] [Related]
6. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Kay DG; Gravel C; Pothier F; Laperrière A; Robitaille Y; Jolicoeur P Proc Natl Acad Sci U S A; 1993 May; 90(10):4538-42. PubMed ID: 8389454 [TBL] [Abstract][Full Text] [Related]
7. Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome. DesGroseillers L; Rassart E; Robitaille Y; Jolicoeur P Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8818-22. PubMed ID: 3866255 [TBL] [Abstract][Full Text] [Related]
8. Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. Lynch WP; Snyder EY; Qualtiere L; Portis JL; Sharpe AH J Virol; 1996 Dec; 70(12):8896-907. PubMed ID: 8971019 [TBL] [Abstract][Full Text] [Related]
9. Neurotropic Cas-BR-E murine leukemia virus harbors several determinants of leukemogenicity mapping in different regions of the genome. Jolicoeur P; DesGroseillers L J Virol; 1985 Nov; 56(2):639-43. PubMed ID: 2997484 [TBL] [Abstract][Full Text] [Related]
10. Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Münk C; Löhler J; Prassolov V; Just U; Stockschläder M; Stocking C Proc Natl Acad Sci U S A; 1997 May; 94(11):5837-42. PubMed ID: 9159161 [TBL] [Abstract][Full Text] [Related]
12. Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Kay DG; Gravel C; Robitaille Y; Jolicoeur P Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1281-5. PubMed ID: 1847516 [TBL] [Abstract][Full Text] [Related]
13. Cellular Prion Protein Combined with Galectin-3 and -6 Affects the Infectivity Titer of an Endogenous Retrovirus Assayed in Hippocampal Neuronal Cells. Kim BH; Shin HY; Goto JJ; Carp RI; Choi EK; Kim YS PLoS One; 2016; 11(12):e0167293. PubMed ID: 27936017 [TBL] [Abstract][Full Text] [Related]
14. Cas-Br-E murine leukemia virus: sequencing of the paralytogenic region of its genome and derivation of specific probes to study its origin and the structure of its recombinant genomes in leukemic tissues. Rassart E; Nelbach L; Jolicoeur P J Virol; 1986 Dec; 60(3):910-9. PubMed ID: 3023680 [TBL] [Abstract][Full Text] [Related]
15. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339 [TBL] [Abstract][Full Text] [Related]
16. Host genetic determinants of neurological disease induced by Cas-Br-M murine leukemia virus. Hoffman PM; Morse HC J Virol; 1985 Jan; 53(1):40-3. PubMed ID: 2981360 [TBL] [Abstract][Full Text] [Related]
18. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG J Virol; 1995 Jan; 69(1):308-19. PubMed ID: 7983723 [TBL] [Abstract][Full Text] [Related]
19. Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313). Howard TM; Sheng Z; Wang M; Wu Y; Rasheed S Virol J; 2006 Dec; 3():101. PubMed ID: 17147829 [TBL] [Abstract][Full Text] [Related]
20. Immunogenic determinants of a neuropathogenic murine leukemia virus. Robbins DS; Remington MP; Sarzotti M; St Louis D; Hoffman PM J Virol; 1995 Nov; 69(11):6847-51. PubMed ID: 7474098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]